Ardelyx Inc ARDX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 04/24/24 EDT
6.43quote price arrow up+0.04 (+0.63%)
Volume
5,429,258
52 week range
3.16 - 10.13
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.43
  • 52 Week High10.13
  • 52 Week High Date02/12/24
  • 52 Week Low3.16
  • 52 Week Low Date10/13/23

Key Stats

  • Market Cap1.496B
  • Shares Out232.69M
  • 10 Day Average Volume4.64M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change3.71

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.43
  • 52 Week High10.13
  • 52 Week High Date02/12/24
  • 52 Week Low3.16
  • 52 Week Low Date10/13/23
  • Market Cap1.496B
  • Shares Out232.69M
  • 10 Day Average Volume4.64M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change3.71

RATIOS/PROFITABILITY

  • EPS (TTM)-0.30
  • P/E (TTM)-21.17
  • Fwd P/E (NTM)-14.26
  • EBITDA (TTM)-61.584M
  • ROE (TTM)-49.83%
  • Revenue (TTM)124.456M
  • Gross Margin (TTM)85.70%
  • Net Margin (TTM)-53.08%
  • Debt To Equity (MRQ)29.87%

EVENTS

  • Earnings Date05/02/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ardelyx Inc

 

Profile

MORE
Ardelyx, Inc. is a biopharmaceutical company. The Company focuses on discovery, development, and commercialization of advanced medicines that meet significant unmet medical needs. It has two commercial products IBSRELA (tenapanor) and XPHOZAH. Its product pipeline includes RDX013 Program and RDX020 Program. Tenapanor is a small molecule therapy in development for the treatment of or the control of hyperphosphatemia or serum phosphorus in adult patients with chronic kidney...
David Mott
Independent Chairman of the Board
Michael Raab
President, Chief Executive Officer, Director
Justin Renz CPA
Chief Financial Officer
Address
34175 Ardenwood Blvd
Fremont, CA
94555-3653
United States

Top Peers

SYMBOLLASTCHG%CHG
RCUS
Arcus Biosciences Inc
15.43-0.07-0.45%
LGND
Ligand Pharmaceuticals Inc
71.00+1.11+1.59%
PTGX
Protagonist Therapeutics Inc
25.70-1.15-4.28%
DCPH
Deciphera Pharmaceuticals Inc
14.62-0.05-0.34%
DVAX
Dynavax Technologies Corp
11.42-0.34-2.89%